Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rupatadine fumarate versus loratadine for allergic rhinitis
ChiCTR-IPR-17013841Phase 4Completed
- Sponsor
- Eye and ENT Hospital of Fudan University
- Start
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of rupatadine in allergic rhinitis (AR) (2 arms), sponsored by Eye and ENT Hospital of Fudan University. Primary endpoint: Efficacy and safety. Started Jan 2008; status: completed.
02
Drugs
rupatadine
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on ChiCTR-IPR-17013841.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17013841.